[1]孙 静,赵东辉.保元汤合人参补肺汤加减治疗老年慢性阻塞性肺疾病稳定期疗效研究[J].陕西中医,2021,(9):1208-1210，1214.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
　SUN Jing,ZHAO Donghui.Efficacy study of Baoyuan decoction and Renshen Bufei decoction in treating stable period of senile chronic obstructive pulmonary disease[J].,2021,(9):1208-1210，1214.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
点击复制

保元汤合人参补肺汤加减治疗老年慢性阻塞性肺疾病稳定期疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年9期
页码:
1208-1210，1214
栏目:
临床研究
出版日期:
2021-09-05

文章信息/Info

Title:
Efficacy study of Baoyuan decoction and Renshen Bufei decoction in treating stable period of senile chronic obstructive pulmonary disease
作者:
孙 静; 赵东辉
(中国中医科学院望京医院,北京 100102)
Author(s):
SUN Jing; ZHAO Donghui
(Wang Jing Hospital of China Academy Chinese Medical Sciences,Beijing 100102,China)
关键词:
性阻塞性肺疾病;  稳定期;  肺肾气阴两虚证;  保元汤;  人参补肺汤;  肺功能;  生活质量
Keywords:
Chronic obstructive pulmonary disease;  Stable period;  Feishen Qiyin Liangxu syndrome;  Baoyuan decoction;  Renshen Bufei decoction;  Lung function;  Life quality
分类号:
R 714.253
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.014
文献标志码:
A
摘要:
目的:探讨保元汤合人参补肺汤加减治疗老年慢性阻塞性肺疾病(COPD)稳定期肺肾气阴两虚证的疗效。方法:将134例COPD稳定期患者随机分为对照组(n=67)和观察组(n=67)。对照组给予西医常规治疗,观察组在对照组基础上给予保元汤合人参补肺汤加减治疗。连续治疗12周后,比较两组肺功能、临床症状和肺肾气阴两虚证评分、临床疗效。结果:治疗后,观察组的改良版英国医学研究委员会呼吸问卷(mMRC)、慢性阻塞性肺疾病自我评估测试问卷(CAT)、肺肾气阴两虚证评分均低于症状对照组,差异有统计学意义(均P<0.01)。与对照组相比,观察组的临床总有效率高于对照组。结论:在西医常规治疗基础上,给予保元汤合人参补肺汤加减治疗老年COPD稳定期肺肾气阴两虚证,能够有效改善患者肺功能、生活质量,临床疗效较好。
Abstract:
Objective:To observe efficacy of Baoyuan decoction and Renshen Bufei decoction in treating stable chronic obstructive pulmonary disease(COPD)patients with Feishen Qiyin Liangxu syndrome.Methods:134 patients with stable COPD were randomly divided into control group(n=67)and observation group(n=67).The control group received conventional western medicine treatment.The observation group was additionally treated with Baoyuan decoction and Renshen Bufei decoction.After 12 weeks treatment,lung function,clinical symptoms,Feishen Qiyin Liangxu syndrome,and clinical efficacy were compared between the two groups.Results:After treatment,scores of improved the medical research council respiratory questionnaire(mMRC),COPD self assessment questionnaire(CAT),scores of symptoms of Feishen Qiyin Liangxu syndrome in the observation group were significantly lower than those in the control group(all P<0.01).Compared with the control group,clinical total effective rate of the observation group was higher than that in the control group.Conclusion:On the basis of conventional western medicine treatment,Baoyuan decoction and Renshen Bufei decoction given to patients with stable stage of COPD of Feishen Qiyin Liangxu syndrome can effectively improve the lung function and quality of life of the patients.

参考文献/References:

[1] Wang C,Xu JY,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China:A national cross-sectional study[J].Lancet,2018,391(10131):1706-1717.
[2] 薛佩妮,冯敏娟,王惠琴.噻托溴铵粉联合糖皮质激素治疗慢性阻塞性肺疾病疗效及对患者生活质量评分的影响[J].陕西医学杂志,2020,49(2):216-219.
[3] 唐万云,曾玉英,汪秀玲,等.益气活血方治疗慢性阻塞性肺疾病稳定期疗效及对患者肺功能、炎症因子的影响[J].陕西中医,2020,41(11):1576-1579,1583.
[4] 桂 坤,杨 俊,龙启忠,等.固肾定喘丸对稳定期肺肾气虚证慢性阻塞性肺疾病患者的康复观察[J].中国实验方剂学杂志,2019,25(8):89-94.
[5] 洪敏俐,郭媛媛,黄锦榕,等.慢性阻塞性肺疾病不同表型中医证型分布规律探讨[J].中华中医药杂志,2018,33(3):1194-1197.
[6] 柯庚申,黄锦榕,杨朝阳,等.肺胀2号方对慢性阻塞性肺疾病稳定期肺肾气阴两虚型患者中医证素的影响[J].新中医,2018,50(12):79-82.
[7] 吴成建,谢贤敏.保元汤辨治急性加重期慢性阻塞性肺疾病30例[J].河南中医,2015,35(9):2167-2168.
[8] 翟海锋,李铃华.人参补肺汤加减治疗稳定期慢性阻塞性肺疾病合并呼吸衰竭肺肾气阴虚证的疗效及对Th1/Th2细胞平衡与相关细胞因子的影响[J].浙江中医杂志,2019,54(9):625-626.
[9] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2013,36(4):255-264.
[10] 中华中医药学会内科分会肺系病专业委员会.慢性阻塞性肺疾病中医证候诊断标准[J].中医杂志,2012,53(1):80-84.
[11] 国家中医药管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-58.
[12] 夏海瑛,钟红卫,徐厚平.COPD稳定期中医证型、体质分布调查及相关性探讨——对我院370人次COPD稳定期患者调查分析[J].西南医科大学学报,2019,42(2):183-186.
[13] 吴孝政,王振兴,刘丽耘,等.慢性阻塞性肺疾病稳定期中医证候分布规律与GOLD 2017综合评估的相关性探讨[J].辽宁中医杂志,2019,46(3):562-566.
[14] 周 晔.平喘固本汤合补肺汤治疗肺肾气虚型慢性阻塞性肺疾病的临床效果观察[J].中医临床研究,2017,9(28):59-60.
[15] 邓明玲,巴 燕,温奕超.稳定期辨证用药对慢性阻塞性肺疾病频繁急性加重表型的获益评价[J].中国实验方剂学杂志,2018,24(16):182-187.
[16] 刘海叶,王亚利,王鑫国,等.养阴益肺方对慢性阻塞性肺疾病稳定期气阴两虚证患者白三烯B4水平的影响[J].中医杂志,2017,58(8):673-677.
[17] 吕佳杰,周明萍.慢性阻塞性肺疾病中医证型与肺功能、CAT评分的相关性分析[J].中华肺部疾病杂志:电子版,2019,12(1):73-76.
[18] 孙树起.润肺滋阴、益气生津法配合西药对慢性阻塞性肺病稳定期(肺肾气阴两虚证)的治疗作用[J].辽宁中医杂志,2018,45(11):2331-2334.
[19] 郭永红,苗深文,富大鹏,等.补益肺肾方治疗慢性阻塞性肺疾病稳定期临床观察[J].中华中医药杂志,2018,33(8):3697-3699.
[20] 唐阿梅,刘良丽,吴 俁.COPD稳定期“肺肾两虚”患者联合使用保元汤和沙美特罗/丙酸氟替卡松吸入剂对肺功能的影响[J].贵州医药,2012,36(7):662-664.
[21] 余 飞,赵栋梁.加味人参补肺汤治疗COPD稳定期肺肾气虚型的临床观察[J].中国中医药科技,2019,26(5):748-750.

相似文献/References:

[1]杨艳菁,蒋 玲△,李 霞.益气通络消癥汤对慢性阻塞性肺疾病患者肺功能及血清sICAM-1、MMP-9水平的影响*[J].陕西中医,2020,(9):1225.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.013]
[2]蔡东林,孙钟和,赵益庆.慢性阻塞性肺疾病稳定期BODE指数、IL-8、TNF-α水平与肺肾气虚证相关性研究*[J].陕西中医,2020,(11):1573.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.015]
[3]唐万云,曾玉英,汪秀玲,等.益气活血方治疗慢性阻塞性肺疾病稳定期疗效及对患者肺功能、炎症因子的影响*[J].陕西中医,2020,(11):1576.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.016]
　TANG Wanyun,ZENG Yuying,WANG Xiuling,et al.Efficacy of Yiqi Huoxue recipe in the treatment of stable COPD and its effect on pulmonary function and inflammatory factors[J].,2020,(9):1576.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.016]
[4]武胜举,王晓青,姚惠青.补肾活血膏方对慢性阻塞性肺疾病稳定期患者抑郁焦虑状态的影响[J].陕西中医,2021,(1):45.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.010]
[5]王海贺,王 璐,李 玲,等.藏红花素对慢性阻塞性肺疾病急性加重期大鼠肺组织NOD样受体蛋白3表达及血清IL-1β水平的影响[J].陕西中医,2022,(7):847.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.007]
　WANG Haihe,WANG Lu,LI Ling,et al.Effects of crocin on the expression of NLRP3 and the level of serum IL-1β in chronic obstructive pulmonary disease acute exacerbation rats[J].,2022,(9):847.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.007]
[6]侯 鑫,庞立健,邹吉宇,等.补肺健脾方联合茚达特罗格隆溴铵治疗老年慢性阻塞性肺疾病疗效研究[J].陕西中医,2022,(12):1694.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.009]
　HOU Xin,PANG Lijian,ZOU Jiyu,et al.Study on effect of Bufei Jianpi recipe combined with indarteroguron ammonium bromide in elderly COPD[J].,2022,(9):1694.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.009]
[7]张 炜,王 彧.揿针治疗肺肾气虚型慢性阻塞性肺疾病稳定期疗效研究[J].陕西中医,2024,(1):115.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.027]
　ZHANG Wei,WANG Yu.Effect of needle therapy in the stable phase of pulmonary and renal qi deficiency chronic obstructive pulmonary disease[J].,2024,(9):115.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.027]
[8]朱海燕,陈淑琴,周 琴.温肺祛痰散对稳定期慢性阻塞性肺疾病患者外周血T淋巴细胞、血清IL-2及sIL-2R的影响[J].陕西中医,2025,46(1):60.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.012]
　ZHU Haiyan,CHEN Shuqin,ZHOU Qin.Effect of Wenfei Qutan powder on peripheral blood T Lymphocytes,serum IL-2 and sIL-2R in stable chronic obstructive pulmonary disease patients[J].,2025,46(9):60.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.012]

备注/Memo

备注/Memo:
基金项目:北京市科学技术委员会项目(Z19110000107109); 中国中医科学院循证能力提升建设项目(ZZ19-024-9)
更新日期/Last Update: 2021-09-10